Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/23/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/18/19 | 8-K | Current report filing |
|
9 | |
| 12/17/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/13/19 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
58 |
